Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Bladder Cancer

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, LW; Chung, CJ; Hsieh, DP; Hsueh, YM; Lee, HL; Lin, P; Liou, SH; Pu, YS1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Bladder Cancer

ArticleYear
Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carcinogens; Female; Guanine; Humans; Male; Middle Aged; Nitrosamines; Pyridines; Smoking; Surveys and Questionnaires; Urinary Bladder Neoplasms

2008